Breaking News From Pharma & Bio Ingredients
Par Begins Shipping Generic Flonase
Posted on 2006-02-23 17:22:00
Par Pharmaceutical Companies, Inc. today announced that it has entered into a supply and distribution agreement with GlaxoSmithKline (GSK) in the United States to distribute fluticasone propionate aqueous nasal spray, 50mcg, which is fully substitutable for GSK's Flonase. Flonase is a synthetic corticosteroid anti-inflammatory agent. It is indicated for the management of the nasal symptoms of seasonal and perennial allergic and nonallergic rhinitis in adults and pediatric patients 4 years of age and older. Annual U.S. sales of Flonase exceed $900 million. Par began shipping fluticasone propionate aqueous nasal spray today.
Subscribe via RSS
